PCT

EnWave Corporation (TSX VENTURE:ENW) ("EnWave", or the "Company") has received
positive comments from the Patent Examiner with regard to the Company's Patent
Co-Operation Treaty ("PCT") patent application for nutraREV(TM) equipment
concept and use, leading the Company to believe that a favorable International
Preliminary Report on Patentability ("IPRP") is forthcoming. The PCT process
allows inventors to obtain patent priority in more than 140 countries at the
same time, thereby saving considerable time and deferring the cost of individual
national filings for 30 months. EnWave has now filed a Canadian national patent
application for the nutraREV(TM) equipment with a request for expedited review
in order to receive an issued patent as quickly as possible. The Company
believes a Canadian patent on this technology will further reinforce its
nutraREV(TM) marketing success which is already protected by six (6) issued
patents.


EnWave holds an expanding intellectual property portfolio designed to protect
the technology and knowledge base of the company. In addition to patent filings
on EnWave's other Radiant Energy Vacuum dehydration processes and equipment, the
Company holds an exclusive world-wide license from the University of British
Columbia for a number of food and biopharmaceutical dehydration patents which
were invented at the UBC laboratory of EnWave's founder and Co-CEO, Dr. Tim
Durance. To-date, the Company has obtained the exclusive global rights to
food-related patents for the dehydration of low-fat snack foods, potato pieces,
krill, medicinal plants, fruit, and berries. The new patent would be the first
one to directly protect the Company's industrial-scale vacuum microwave food
dehydration equipment.


"EnWave has a long-standing commi(TM)ent to the patent process in order to
protect our valuable technology from unlicensed manufacture and use," stated Dr.
Tim Durance, EnWave's Chairman & Co-CEO. "As a research and development
organization, patents are a critical step in the bid to commercialize our
Radiant Energy Vacuum dehydration technologies for food, food cultures and
biopharmaceuticals. We expect to sell equipment and collect royalties throughout
much of the world, making wide patent coverage valuable."


EnWave expects that the Canadian patent will be reviewed over the next few
months, and a decision announced in Q1, 2010. The Company will then proceed with
further national filings to ensure protection in major markets throughout the
world.


About EnWave

Using proprietary technologies developed in conjunction with the University of
British Columbia, EnWave is focused on the development of new methods of
dehydrating food and biological materials using Radiant Energy Vacuum technology
under its nutraREV(TM), powderREV, bioREV(TM) and freezeREV brands. REV
technology combines microwave energy transfer under vacuum to dehydrate and
alter structures and drive chemical reactions, thereby creating unique product
characteristics for both food products and medical applications that include
fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and
antibodies. More information about EnWave is available at www.enwave.net.


EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

This press release may contain forward-looking information based on management's
expectations, estimates and projections. All statements that address
expectations or projections about the future, including statements about the
Company's strategy for growth, product development, market position, expected
expenditures and financial results are forward-looking statements. These
statements are not a guarantee of future performance and involve a number of
risks, uncertainties and assumptions: there is no guarantee that the Company's
REV technology can or will improve dehydration processes in the target
industries; even if the Company's REV technology can be used as described in
this document, there is no guarantee that such use will result in orders for the
Company's REV technology.

(TSXV:PCT)
Historical Stock Chart
From May 2024 to Jun 2024

(TSXV:PCT)
Historical Stock Chart
From Jun 2023 to Jun 2024